Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 6/20 | 0.45 |
| ▸ | EHMT1 | Q9H9B1 | 6/20 | 0.45 |
| ▸ | SPIN1 | Q9Y657 | 1/20 | 0.39 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | KMT5A | Q9NQR1 | 2/20 | 0.36 |
| ▸ | NSD2 | O96028 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.33 |
| ▸ | TUBB | P07437 | 1/20 | 0.33 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.33 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.33 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.33 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.33 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.33 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.33 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.33 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.33 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.33 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.33 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5421592 | 0.90 | EHMT2 (0.39) | EHMT2EHMT1SPIN1SLC2A1KMT5A | |
| SCHEMBL6919803 | 0.89 | EHMT2 (0.45) | EHMT2EHMT1SPIN1SLC2A1KMT5A | |
| Citric Acid SCHEMBL6865211 | 0.89 | EHMT2 (0.37) | EHMT2EHMT1SPIN1SLC2A1KMT5A | |
| SCHEMBL6863012 | 0.88 | SLC6A2 (0.34) | EHMT2EHMT1SPIN1SLC2A1KMT5A | |
| SCHEMBL6430010 | 0.88 | EHMT2 (0.37) | EHMT2EHMT1SPIN1NMT1HTR2A | |
| SCHEMBL6921934 | 0.87 | EHMT2 (0.38) | EHMT2EHMT1SPIN1SLC2A1KMT5A | |
| SCHEMBL6234157 | 0.85 | NMT1 (0.37) | EHMT2EHMT1NMT1JAK2HTR2A | |
| SCHEMBL6818739 | 0.85 | SMN1; SMN2 (0.46) | EHMT2EHMT1HRH4ALDH1A1KDM4E | |
| SCHEMBL5032272 | 0.85 | SMN1; SMN2 (0.48) | EHMT2EHMT1HRH4ALDH1A1KDM4E | |
| SCHEMBL5412219 | 0.84 | EHMT2 (0.41) | EHMT2EHMT1SPIN1SLC2A1KMT5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1560817-A1 | METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS | Reddy US Therapeutics, Inc. (US) | 2005-08-10 | — | — | EP | disclosed |
| US-20040209880-A1 | Methods and compositions of novel triazine compounds | DR. REDDY'S LABORATORIES LTD. (IN) | 2004-10-21 | — | — | US | disclosed |
| WO-2004026844-A1 | METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS | REDDY US THERAPEUTICS, INC. (US) | 2004-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209880-A1 | Methods and compositions of novel triazine compounds | AREG, TGFB1, PTGIS | EHMT2 2905/4885EHMT1 2811/4885SPIN1 4353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.